HOME >> MEDICINE >> NEWS
$10 million gift funds innovative predictive health study

his innovative cardiovascular research project.

"Cardiovascular disease is the single largest killer in the United States," said Dr. March. "We need to better understand who is at risk for this disease and how to reduce that risk. This institute should provide valuable information and a unique window into the future health of Americans because we are studying, in parallel, genes, proteins and characteristics of repair cells, as well as individual health behaviors and how all these factors interact to contribute to each individualTMs cardiovascular health or disease over time."

Volunteers for the study initially will be sought among people preparing to undergo heart catheterizations at the Clarian Cardiovascular Center, but the study will eventually expand to a wider population of participants. Calling the study "the next generation of cardiac research," Dr. March said the results should identify sets of markers (signatures) that are predictive for heart disease, and help us understand how to lower risk.

Volunteers will be monitored over many years to understand how their blood vessel status and heart health change over time. Such longitudinal data can help researchers understand biological compensation " the ability of some individuals to overcome, while others succumb to the same risk factors. Integrating detailed social and behavioral information with the biological factors will help researchers answer the questions about how genes and the environment interact to raise or lower the risk of disease.

"For example, biological data may enable researchers to understand how healthy behaviors, such as exercise, change the cardiovascular system at the level of proteins, cells and cell structures," said Dr. March.

Initially, 1,000 participants will be enrolled in the study and researchers will collect information on their lifestyle behavior over a period of years. Biological data from blood analysis will be collected
'"/>

Contact: Mary Hardin or Cindy Fox Aisen
mhardin@iupui.edu
317-274-7722
Indiana University
21-Mar-2006


Page: 1 2 3 4

Related medicine news :

1. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
2. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
3. FPG receives $8 million for autism research
4. CIRM awards $3.79 million to Burnham Institute
5. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
6. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
7. Mayor of New York proposes preventing 100 million deaths from tobacco
8. Menzies School of Health Research receives $5.3 million in Federal Budget
9. $30 million boost to dementia research
10. $1.5 million awarded for palliative care research
11. $7.5 million NIH grant to Yale for Autism Center of Excellence

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: million gift funds innovative predictive health study

(Date:5/21/2013)... Spring is the perfect time to ... filled with whole foods to weather perfect for outdoor ... season the nutrition experts at Brilliant Nutrition highlight five ... , 1. Eating Locally, With the abundance of fresh ... and explore, spring is a great time to take ...
(Date:5/21/2013)... Standard advice for mattress shoppers often consists ... given industry’s less than exceptional satisfaction ratings and the ... Consumer Mattress Reports sets out to revise this advice ... .” , This article addresses several components of the ... not be readily apparent to many shoppers. From prices ...
(Date:5/21/2013)... Patients of Dr. Michael Shenk and Dr. Judd Shenk ... gum disease and would like permanent tooth replacements now have ... laser gum surgery. Gum disease must be treated prior ... of all tooth replacement options. , The Laser Assisted ... by the Food and Drug Administration (FDA) that greatly improves ...
(Date:5/21/2013)... analogues (PGAs), drugs which lower intraocular pressure, are often ... but their use is not without risks. PGAs have ... eye color and other side effects. Now a new ... and lower eyelid drooping and other issues that can ... PLOS ONE . , Researchers from the Massachusetts Eye ...
(Date:5/21/2013)... 2013 HealthSmart continues to grow through ... has required the hiring of new talent in several ... to announce that Dawn Powell has joined the organization ... Director of Account Management in the Central Region and ... Texas. With extensive client management, employee benefits, and product ...
Breaking Medicine News(10 mins):Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Choosing the Best Mattress Simplified in Consumer Mattress Reports’ Latest Article 2Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2
(Date:5/21/2013)... May 21, 2013 BioElectronics Corp. (PINKSHEETS: ... electronic devices, announced that CEO, Andrew ... the FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation ... for over the counter sales. "It,s ... medical device classification schema," Whelan said.  "While the ...
(Date:5/21/2013)... TARRYTOWN, N.Y. , May 21, 2013 ... Inc. (NASDAQ: REGN) today announced that the New ... Phase 2a study results of dupilumab (SAR231893/REGN668) in patients ... antibody targeting the alpha subunit of the interleukin 4 ... and IL-13, drivers of Th2 (Type 2 helper T ...
(Date:5/21/2013)... 2013 U.S. spending on specialty prescription drugs ... as cancer, multiple sclerosis and rheumatoid arthritis — is ... 2015, according to a forecast released today by Express ... ) "As we see what,s on ... to act so they can continue to offer an ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
Cached News: